Schedule 13G ownership disclosure

LIXTE BIOTECHNOLOGY HLDGS IN

Common Stock, par value $0.0001 per share · CUSIP: 539319301

Event date: 2025-02-14

Filing-level shares
120,012.00
Percent of class
4.5%
  • Orca Capital AG

    Shares: 120,012.00 · Class: 4.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-25-007178
Form type
SCHEDULE 13G/A
Filer
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
CIK
CIK 1335105
Filed
Feb 18, 2025
Reporting period
Feb 14, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub